Kiromic Biopharma, Inc. Business Finance Contracts & Agreements

54 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2024
Form of Exchange Agreement dated as of November 1, 2024 between the Company and the holder of the Exchange Notes
Exchange Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2024
Form of Exchange Agreement dated as of September 27, 2024 between the Company and the holder of the Exchange Securities
Exchange Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2024
25% Senior Secured Convertible Promissory Note, dated August 1, 2024
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2024
First Amendment to 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2024
25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2024
25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2024
Exchange Agreement dated as of June 21, 2024 between the Company and the Holder
Exchange Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2024
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2024
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2024
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2024
Form of Exchange Agreement dated as of March 28, 2024 between the Company and the holder of the Exchange Securities
Exchange Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2024
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2024
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2024
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2024
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2023
Form of Exchange Agreement dated as of July 18, 2023 between the Company and the holder of the Exchange Securities
Exchange Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2023
Form of Exchange Agreement dated as of March 28, 2023 between the Company and the holder of the Exchange Securities
Exchange Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2023
Form of Note Purchase Agreement
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2023
Form of the Amended and Restated 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022
Amended Stipulation of Settlement and Mutual Release, dated October 27, 2022, by and among Kiromic Biopharma, Inc., Sabby Volatility Warrant Master Fund Ltd. and other parties
Warrant Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022
Standby Equity Purchase Agreement, dated October 13, 2022, by and between Kiromic Biopharma, Inc. and YA II PN, Ltd
Purchase Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022
Form of the Subordinated Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022
Stipulation of Settlement and Mutual Release, dated October 10, 2022, by and among Kiromic Biopharma, Inc., Sabby Volatility Warrant Master Fund Ltd. and other parties
Warrant Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022
Form of Representatives Warrant
Warrant Agreements
Kiromic Biopharma, Inc.
Biotechnology
2022
Form of Pre-Funded Warrant
Warrant Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022
Form of Warrant Agent Agreement
Warrant Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022
Form of Common Stock Warrants
Stock Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022
Form of Underwriting Agreement
Underwriting Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022